Skip to main content

LIMP-2 as a Scaffolding Protein to Characterize PD-Associated GCase Variants

This grant builds upon the research from a prior grant: Structural Characterization of the GCase/LIMP-2 Complex

Promising Outcomes of Original Grant:
Our original grant focused on determining the structure of the complex formed by the Parkinson’s-associated protein beta-gluccocerebrosidase (GCase) and its transporter LIMP-2. About seven to 12 percent of Parkinson’s patients carry mutations in the gene encoding for GCase. The two proteins LIMP-2 and GCase meet in the cell and then travel together to the lysosome, a cellular compartment important for cellular waste removal. In previous work, we found that LIMP-2 can increase GCase activity. After determining the structure of this protein complex we want to utilize the contact site for the design of a GCase activator. Activators for GCase are promising candidates for clinical intervention in Parkinson’s patients. Some activators for GCase are in clinical trials right now.

Objectives for Supplemental Investigation:    
In the proposed project we will also include GCase variants associated with Parkinson’s. Therefore, we will use LIMP-2 as a tool to harvest GCase from cell culture and use different biochemical methods to test the complex properties. We were also able to determine a preliminary structure of the complex and in this project, we will continue our investigation on this matter. We will also include the Parkinson’s-associated variants into our structural project. Structures of these Parkinson’s-associated protein complexes will eventually shed light on how the mutations influence complex stability and thereby enzymatic activity of GCase.

Importance of This Research for the Development of a New PD Therapy:    
As LIMP-2 increases GCase activity, exact understanding of the interaction site will open new doors for the development of GCase activators. 


Discover More Grants

Within the Same Program

Within the Same Funding Year

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.